RESTRICTED STOCK (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Stock Options And Restricted Stock
Non-cash compensation expense	$ 188,000	$ 161,000
Aggregate restricted shares of Common Stock pursuant to 2008 plan	17,136
Shares of non-vested restricted stock	182,429
Total unrecognized compensation expense	$ 763,000
FDA Approval [Member]
Stock Options And Restricted Stock
Restricted stock to vest upon FDA approval	54,510
Yearly [Member]
Stock Options And Restricted Stock
Restricted stock to vest upon FDA approval	127,919